nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CXCL8—ovarian cancer	0.34	0.801	CbGaD
Diclofenac—ABCB1—ovarian cancer	0.0844	0.199	CbGaD
Diclofenac—UGT2B7—Epirubicin—ovarian cancer	0.0517	0.184	CbGbCtD
Diclofenac—ABCC1—Epirubicin—ovarian cancer	0.0367	0.131	CbGbCtD
Diclofenac—ABCC1—Paclitaxel—ovarian cancer	0.0362	0.129	CbGbCtD
Diclofenac—ABCC1—Docetaxel—ovarian cancer	0.0262	0.0931	CbGbCtD
Diclofenac—ABCC1—Doxorubicin—ovarian cancer	0.0195	0.0694	CbGbCtD
Diclofenac—ABCB1—Topotecan—ovarian cancer	0.0177	0.0628	CbGbCtD
Diclofenac—CYP2C8—Paclitaxel—ovarian cancer	0.0129	0.0459	CbGbCtD
Diclofenac—ABCB1—Vinorelbine—ovarian cancer	0.0124	0.0442	CbGbCtD
Diclofenac—CYP3A4—Topotecan—ovarian cancer	0.0106	0.0376	CbGbCtD
Diclofenac—CYP2B6—Doxorubicin—ovarian cancer	0.00919	0.0327	CbGbCtD
Diclofenac—CYP2C9—Paclitaxel—ovarian cancer	0.00901	0.032	CbGbCtD
Diclofenac—ABCB1—Paclitaxel—ovarian cancer	0.00874	0.0311	CbGbCtD
Diclofenac—CYP3A4—Vinorelbine—ovarian cancer	0.00745	0.0265	CbGbCtD
Diclofenac—ABCB1—Docetaxel—ovarian cancer	0.00632	0.0225	CbGbCtD
Diclofenac—CYP3A4—Paclitaxel—ovarian cancer	0.00524	0.0186	CbGbCtD
Diclofenac—ABCB1—Doxorubicin—ovarian cancer	0.00471	0.0167	CbGbCtD
Diclofenac—CYP3A4—Docetaxel—ovarian cancer	0.00379	0.0135	CbGbCtD
Diclofenac—CYP3A4—Doxorubicin—ovarian cancer	0.00282	0.01	CbGbCtD
Diclofenac—PTGS2—ovarian follicle—ovarian cancer	0.00269	0.0434	CbGeAlD
Diclofenac—CXCR1—bone marrow—ovarian cancer	0.00221	0.0357	CbGeAlD
Diclofenac—PLA2G2A—myometrium—ovarian cancer	0.00144	0.0232	CbGeAlD
Diclofenac—CXCL8—myometrium—ovarian cancer	0.00142	0.023	CbGeAlD
Diclofenac—ASIC1—female reproductive system—ovarian cancer	0.00139	0.0225	CbGeAlD
Diclofenac—CXCR1—lymph node—ovarian cancer	0.00137	0.0221	CbGeAlD
Diclofenac—ASIC1—female gonad—ovarian cancer	0.00127	0.0205	CbGeAlD
Diclofenac—PTGS1—oviduct—ovarian cancer	0.00123	0.02	CbGeAlD
Diclofenac—KCNQ2—gonad—ovarian cancer	0.00114	0.0184	CbGeAlD
Diclofenac—PLA2G2A—epithelium—ovarian cancer	0.00113	0.0182	CbGeAlD
Diclofenac—ASIC1—testis—ovarian cancer	0.00112	0.0181	CbGeAlD
Diclofenac—CXCL8—uterine cervix—ovarian cancer	0.00111	0.0179	CbGeAlD
Diclofenac—KCNQ3—female reproductive system—ovarian cancer	0.00111	0.0179	CbGeAlD
Diclofenac—PLA2G2A—decidua—ovarian cancer	0.00107	0.0172	CbGeAlD
Diclofenac—CXCL8—decidua—ovarian cancer	0.00106	0.0171	CbGeAlD
Diclofenac—TTR—embryo—ovarian cancer	0.00104	0.0169	CbGeAlD
Diclofenac—CYP2C18—uterine cervix—ovarian cancer	0.00102	0.0165	CbGeAlD
Diclofenac—KCNQ2—female reproductive system—ovarian cancer	0.00102	0.0165	CbGeAlD
Diclofenac—PLA2G2A—endometrium—ovarian cancer	0.00101	0.0164	CbGeAlD
Diclofenac—CXCL8—endometrium—ovarian cancer	0.001	0.0162	CbGeAlD
Diclofenac—KCNQ2—female gonad—ovarian cancer	0.000927	0.015	CbGeAlD
Diclofenac—PLA2G2A—female reproductive system—ovarian cancer	0.000839	0.0136	CbGeAlD
Diclofenac—KCNQ2—testis—ovarian cancer	0.000822	0.0133	CbGeAlD
Diclofenac—ASIC1—lymph node—ovarian cancer	0.000814	0.0132	CbGeAlD
Diclofenac—CXCL8—bone marrow—ovarian cancer	0.000784	0.0127	CbGeAlD
Diclofenac—PLA2G2A—female gonad—ovarian cancer	0.000763	0.0123	CbGeAlD
Diclofenac—CXCL8—female gonad—ovarian cancer	0.000756	0.0122	CbGeAlD
Diclofenac—CXCL8—vagina—ovarian cancer	0.000751	0.0121	CbGeAlD
Diclofenac—ALOX5—decidua—ovarian cancer	0.00073	0.0118	CbGeAlD
Diclofenac—UGT2B7—female reproductive system—ovarian cancer	0.000706	0.0114	CbGeAlD
Diclofenac—CYP2C18—vagina—ovarian cancer	0.000693	0.0112	CbGeAlD
Diclofenac—SLC22A11—female reproductive system—ovarian cancer	0.000688	0.0111	CbGeAlD
Diclofenac—PLA2G2A—testis—ovarian cancer	0.000677	0.0109	CbGeAlD
Diclofenac—CXCL8—testis—ovarian cancer	0.00067	0.0108	CbGeAlD
Diclofenac—TTR—female reproductive system—ovarian cancer	0.000633	0.0102	CbGeAlD
Diclofenac—TTR—bone marrow—ovarian cancer	0.000598	0.00966	CbGeAlD
Diclofenac—ALOX5—female reproductive system—ovarian cancer	0.000574	0.00927	CbGeAlD
Diclofenac—ABCC1—myometrium—ovarian cancer	0.000572	0.00925	CbGeAlD
Diclofenac—SLCO1C1—testis—ovarian cancer	0.000572	0.00924	CbGeAlD
Diclofenac—UGT2B7—testis—ovarian cancer	0.00057	0.00921	CbGeAlD
Diclofenac—ALOX5—bone marrow—ovarian cancer	0.000542	0.00875	CbGeAlD
Diclofenac—SCN4A—testis—ovarian cancer	0.000525	0.00849	CbGeAlD
Diclofenac—ALOX5—female gonad—ovarian cancer	0.000522	0.00844	CbGeAlD
Diclofenac—TTR—testis—ovarian cancer	0.000511	0.00826	CbGeAlD
Diclofenac—PLA2G2A—lymph node—ovarian cancer	0.000491	0.00793	CbGeAlD
Diclofenac—CXCL8—lymph node—ovarian cancer	0.000486	0.00785	CbGeAlD
Diclofenac—ALOX5—testis—ovarian cancer	0.000463	0.00748	CbGeAlD
Diclofenac—ABCC1—uterine cervix—ovarian cancer	0.000445	0.0072	CbGeAlD
Diclofenac—ABCC4—uterus—ovarian cancer	0.000435	0.00703	CbGeAlD
Diclofenac—ABCC1—decidua—ovarian cancer	0.000424	0.00686	CbGeAlD
Diclofenac—SLCO1C1—lymph node—ovarian cancer	0.000414	0.0067	CbGeAlD
Diclofenac—ABCC1—endometrium—ovarian cancer	0.000403	0.00651	CbGeAlD
Diclofenac—ABCC4—female reproductive system—ovarian cancer	0.000391	0.00632	CbGeAlD
Diclofenac—PTGS2—myometrium—ovarian cancer	0.000378	0.0061	CbGeAlD
Diclofenac—ABCC1—uterus—ovarian cancer	0.000371	0.006	CbGeAlD
Diclofenac—ABCC4—bone marrow—ovarian cancer	0.000369	0.00597	CbGeAlD
Diclofenac—PTGS2—embryo—ovarian cancer	0.000363	0.00587	CbGeAlD
Diclofenac—ABCC4—female gonad—ovarian cancer	0.000356	0.00575	CbGeAlD
Diclofenac—CYP1A1—epithelium—ovarian cancer	0.000353	0.0057	CbGeAlD
Diclofenac—CYP1A1—uterine cervix—ovarian cancer	0.00035	0.00565	CbGeAlD
Diclofenac—CYP2C8—endometrium—ovarian cancer	0.000343	0.00554	CbGeAlD
Diclofenac—ALOX5—lymph node—ovarian cancer	0.000336	0.00542	CbGeAlD
Diclofenac—ALB—testis—ovarian cancer	0.000326	0.00527	CbGeAlD
Diclofenac—ABCC4—testis—ovarian cancer	0.000316	0.0051	CbGeAlD
Diclofenac—PTGS1—epithelium—ovarian cancer	0.00031	0.00501	CbGeAlD
Diclofenac—PTGS1—uterine cervix—ovarian cancer	0.000307	0.00497	CbGeAlD
Diclofenac—ABCC1—female gonad—ovarian cancer	0.000304	0.00491	CbGeAlD
Diclofenac—ABCC1—vagina—ovarian cancer	0.000302	0.00488	CbGeAlD
Diclofenac—PTGS2—epithelium—ovarian cancer	0.000296	0.00479	CbGeAlD
Diclofenac—CYP2C19—vagina—ovarian cancer	0.000294	0.00476	CbGeAlD
Diclofenac—PTGS2—uterine cervix—ovarian cancer	0.000294	0.00475	CbGeAlD
Diclofenac—CYP1A1—uterus—ovarian cancer	0.000292	0.00471	CbGeAlD
Diclofenac—CYP2B6—gonad—ovarian cancer	0.000285	0.00461	CbGeAlD
Diclofenac—CYP2C8—female reproductive system—ovarian cancer	0.000284	0.00459	CbGeAlD
Diclofenac—PTGS1—endometrium—ovarian cancer	0.000278	0.00449	CbGeAlD
Diclofenac—ABCC1—testis—ovarian cancer	0.000269	0.00435	CbGeAlD
Diclofenac—PTGS2—endometrium—ovarian cancer	0.000266	0.00429	CbGeAlD
Diclofenac—CYP1A1—female reproductive system—ovarian cancer	0.000262	0.00424	CbGeAlD
Diclofenac—CYP2C8—vagina—ovarian cancer	0.000257	0.00415	CbGeAlD
Diclofenac—PTGS1—uterus—ovarian cancer	0.000256	0.00414	CbGeAlD
Diclofenac—CYP2B6—female reproductive system—ovarian cancer	0.000255	0.00412	CbGeAlD
Diclofenac—CYP2C9—female reproductive system—ovarian cancer	0.000252	0.00408	CbGeAlD
Diclofenac—PTGS2—uterus—ovarian cancer	0.000245	0.00396	CbGeAlD
Diclofenac—CYP2E1—female reproductive system—ovarian cancer	0.000239	0.00386	CbGeAlD
Diclofenac—CYP1A1—female gonad—ovarian cancer	0.000239	0.00386	CbGeAlD
Diclofenac—CYP1A1—vagina—ovarian cancer	0.000237	0.00383	CbGeAlD
Diclofenac—ALB—lymph node—ovarian cancer	0.000236	0.00382	CbGeAlD
Diclofenac—ABCB1—myometrium—ovarian cancer	0.000234	0.00377	CbGeAlD
Diclofenac—CYP2B6—vagina—ovarian cancer	0.00023	0.00372	CbGeAlD
Diclofenac—PTGS1—female reproductive system—ovarian cancer	0.00023	0.00372	CbGeAlD
Diclofenac—CYP2C8—testis—ovarian cancer	0.000229	0.0037	CbGeAlD
Diclofenac—ABCC4—lymph node—ovarian cancer	0.000229	0.0037	CbGeAlD
Diclofenac—ABCB1—embryo—ovarian cancer	0.000225	0.00363	CbGeAlD
Diclofenac—PTGS2—female reproductive system—ovarian cancer	0.00022	0.00356	CbGeAlD
Diclofenac—PTGS1—female gonad—ovarian cancer	0.00021	0.00339	CbGeAlD
Diclofenac—PTGS1—vagina—ovarian cancer	0.000208	0.00337	CbGeAlD
Diclofenac—PTGS2—bone marrow—ovarian cancer	0.000208	0.00336	CbGeAlD
Diclofenac—CYP2B6—testis—ovarian cancer	0.000206	0.00332	CbGeAlD
Diclofenac—PTGS2—female gonad—ovarian cancer	0.0002	0.00324	CbGeAlD
Diclofenac—PTGS2—vagina—ovarian cancer	0.000199	0.00322	CbGeAlD
Diclofenac—ABCC1—lymph node—ovarian cancer	0.000195	0.00315	CbGeAlD
Diclofenac—CYP2E1—testis—ovarian cancer	0.000193	0.00312	CbGeAlD
Diclofenac—CYP3A4—female reproductive system—ovarian cancer	0.000192	0.00311	CbGeAlD
Diclofenac—PTGS1—testis—ovarian cancer	0.000186	0.003	CbGeAlD
Diclofenac—ABCB1—epithelium—ovarian cancer	0.000183	0.00296	CbGeAlD
Diclofenac—ABCB1—uterine cervix—ovarian cancer	0.000182	0.00294	CbGeAlD
Diclofenac—ABCB1—decidua—ovarian cancer	0.000173	0.0028	CbGeAlD
Diclofenac—ABCB1—endometrium—ovarian cancer	0.000164	0.00266	CbGeAlD
Diclofenac—CYP1A1—lymph node—ovarian cancer	0.000153	0.00248	CbGeAlD
Diclofenac—ABCB1—gonad—ovarian cancer	0.000153	0.00246	CbGeAlD
Diclofenac—ABCB1—uterus—ovarian cancer	0.000152	0.00245	CbGeAlD
Diclofenac—ABCB1—female reproductive system—ovarian cancer	0.000136	0.0022	CbGeAlD
Diclofenac—PTGS1—lymph node—ovarian cancer	0.000135	0.00218	CbGeAlD
Diclofenac—PTGS2—lymph node—ovarian cancer	0.000129	0.00208	CbGeAlD
Diclofenac—ABCB1—bone marrow—ovarian cancer	0.000129	0.00208	CbGeAlD
Diclofenac—ABCB1—female gonad—ovarian cancer	0.000124	0.002	CbGeAlD
Diclofenac—ABCB1—vagina—ovarian cancer	0.000123	0.00199	CbGeAlD
Diclofenac—ABCB1—testis—ovarian cancer	0.00011	0.00178	CbGeAlD
Diclofenac—ABCB1—lymph node—ovarian cancer	7.97e-05	0.00129	CbGeAlD
Diclofenac—Anaphylactic shock—Docetaxel—ovarian cancer	6.39e-05	0.000408	CcSEcCtD
Diclofenac—Weight increased—Doxorubicin—ovarian cancer	6.39e-05	0.000407	CcSEcCtD
Diclofenac—Epistaxis—Epirubicin—ovarian cancer	6.38e-05	0.000407	CcSEcCtD
Diclofenac—Infection—Docetaxel—ovarian cancer	6.35e-05	0.000405	CcSEcCtD
Diclofenac—Weight decreased—Doxorubicin—ovarian cancer	6.35e-05	0.000405	CcSEcCtD
Diclofenac—Sinusitis—Epirubicin—ovarian cancer	6.34e-05	0.000405	CcSEcCtD
Diclofenac—Hyperglycaemia—Doxorubicin—ovarian cancer	6.33e-05	0.000404	CcSEcCtD
Diclofenac—Agranulocytosis—Epirubicin—ovarian cancer	6.31e-05	0.000402	CcSEcCtD
Diclofenac—Pneumonia—Doxorubicin—ovarian cancer	6.29e-05	0.000401	CcSEcCtD
Diclofenac—Shock—Docetaxel—ovarian cancer	6.29e-05	0.000401	CcSEcCtD
Diclofenac—Nervous system disorder—Docetaxel—ovarian cancer	6.27e-05	0.0004	CcSEcCtD
Diclofenac—Thrombocytopenia—Docetaxel—ovarian cancer	6.26e-05	0.000399	CcSEcCtD
Diclofenac—Infestation NOS—Doxorubicin—ovarian cancer	6.26e-05	0.000399	CcSEcCtD
Diclofenac—Drowsiness—Doxorubicin—ovarian cancer	6.26e-05	0.000399	CcSEcCtD
Diclofenac—Infestation—Doxorubicin—ovarian cancer	6.26e-05	0.000399	CcSEcCtD
Diclofenac—Tachycardia—Docetaxel—ovarian cancer	6.24e-05	0.000398	CcSEcCtD
Diclofenac—Feeling abnormal—Paclitaxel—ovarian cancer	6.22e-05	0.000396	CcSEcCtD
Diclofenac—Skin disorder—Docetaxel—ovarian cancer	6.21e-05	0.000396	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	6.2e-05	0.000396	CcSEcCtD
Diclofenac—Bradycardia—Epirubicin—ovarian cancer	6.18e-05	0.000394	CcSEcCtD
Diclofenac—Gastrointestinal pain—Paclitaxel—ovarian cancer	6.17e-05	0.000393	CcSEcCtD
Diclofenac—Renal failure—Doxorubicin—ovarian cancer	6.15e-05	0.000392	CcSEcCtD
Diclofenac—Neuropathy peripheral—Doxorubicin—ovarian cancer	6.13e-05	0.000391	CcSEcCtD
Diclofenac—Haemoglobin—Epirubicin—ovarian cancer	6.1e-05	0.000389	CcSEcCtD
Diclofenac—Stomatitis—Doxorubicin—ovarian cancer	6.1e-05	0.000389	CcSEcCtD
Diclofenac—Jaundice—Doxorubicin—ovarian cancer	6.1e-05	0.000389	CcSEcCtD
Diclofenac—Anorexia—Docetaxel—ovarian cancer	6.09e-05	0.000389	CcSEcCtD
Diclofenac—Rhinitis—Epirubicin—ovarian cancer	6.09e-05	0.000388	CcSEcCtD
Diclofenac—Conjunctivitis—Doxorubicin—ovarian cancer	6.08e-05	0.000388	CcSEcCtD
Diclofenac—Urinary tract infection—Doxorubicin—ovarian cancer	6.08e-05	0.000388	CcSEcCtD
Diclofenac—Hepatitis—Epirubicin—ovarian cancer	6.07e-05	0.000387	CcSEcCtD
Diclofenac—Haemorrhage—Epirubicin—ovarian cancer	6.07e-05	0.000387	CcSEcCtD
Diclofenac—Hypoaesthesia—Epirubicin—ovarian cancer	6.04e-05	0.000385	CcSEcCtD
Diclofenac—Pharyngitis—Epirubicin—ovarian cancer	6.02e-05	0.000384	CcSEcCtD
Diclofenac—Sweating—Doxorubicin—ovarian cancer	6e-05	0.000383	CcSEcCtD
Diclofenac—Urinary tract disorder—Epirubicin—ovarian cancer	5.99e-05	0.000382	CcSEcCtD
Diclofenac—Urticaria—Paclitaxel—ovarian cancer	5.99e-05	0.000382	CcSEcCtD
Diclofenac—Oedema peripheral—Epirubicin—ovarian cancer	5.98e-05	0.000381	CcSEcCtD
Diclofenac—Hypotension—Docetaxel—ovarian cancer	5.97e-05	0.000381	CcSEcCtD
Diclofenac—Haematuria—Doxorubicin—ovarian cancer	5.97e-05	0.00038	CcSEcCtD
Diclofenac—Abdominal pain—Paclitaxel—ovarian cancer	5.96e-05	0.00038	CcSEcCtD
Diclofenac—Body temperature increased—Paclitaxel—ovarian cancer	5.96e-05	0.00038	CcSEcCtD
Diclofenac—Urethral disorder—Epirubicin—ovarian cancer	5.95e-05	0.000379	CcSEcCtD
Diclofenac—Hepatobiliary disease—Doxorubicin—ovarian cancer	5.92e-05	0.000377	CcSEcCtD
Diclofenac—Epistaxis—Doxorubicin—ovarian cancer	5.9e-05	0.000376	CcSEcCtD
Diclofenac—Sinusitis—Doxorubicin—ovarian cancer	5.87e-05	0.000374	CcSEcCtD
Diclofenac—Visual impairment—Epirubicin—ovarian cancer	5.85e-05	0.000373	CcSEcCtD
Diclofenac—Agranulocytosis—Doxorubicin—ovarian cancer	5.84e-05	0.000372	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Docetaxel—ovarian cancer	5.82e-05	0.000372	CcSEcCtD
Diclofenac—Insomnia—Docetaxel—ovarian cancer	5.78e-05	0.000369	CcSEcCtD
Diclofenac—Paraesthesia—Docetaxel—ovarian cancer	5.74e-05	0.000366	CcSEcCtD
Diclofenac—Erythema multiforme—Epirubicin—ovarian cancer	5.74e-05	0.000366	CcSEcCtD
Diclofenac—Bradycardia—Doxorubicin—ovarian cancer	5.72e-05	0.000365	CcSEcCtD
Diclofenac—Dyspnoea—Docetaxel—ovarian cancer	5.7e-05	0.000364	CcSEcCtD
Diclofenac—Somnolence—Docetaxel—ovarian cancer	5.68e-05	0.000363	CcSEcCtD
Diclofenac—Eye disorder—Epirubicin—ovarian cancer	5.67e-05	0.000362	CcSEcCtD
Diclofenac—Tinnitus—Epirubicin—ovarian cancer	5.66e-05	0.000361	CcSEcCtD
Diclofenac—Haemoglobin—Doxorubicin—ovarian cancer	5.64e-05	0.00036	CcSEcCtD
Diclofenac—Flushing—Epirubicin—ovarian cancer	5.63e-05	0.000359	CcSEcCtD
Diclofenac—Cardiac disorder—Epirubicin—ovarian cancer	5.63e-05	0.000359	CcSEcCtD
Diclofenac—Rhinitis—Doxorubicin—ovarian cancer	5.63e-05	0.000359	CcSEcCtD
Diclofenac—Dyspepsia—Docetaxel—ovarian cancer	5.63e-05	0.000359	CcSEcCtD
Diclofenac—Haemorrhage—Doxorubicin—ovarian cancer	5.62e-05	0.000358	CcSEcCtD
Diclofenac—Hepatitis—Doxorubicin—ovarian cancer	5.62e-05	0.000358	CcSEcCtD
Diclofenac—Hypoaesthesia—Doxorubicin—ovarian cancer	5.59e-05	0.000356	CcSEcCtD
Diclofenac—Pharyngitis—Doxorubicin—ovarian cancer	5.57e-05	0.000356	CcSEcCtD
Diclofenac—Decreased appetite—Docetaxel—ovarian cancer	5.56e-05	0.000354	CcSEcCtD
Diclofenac—Hypersensitivity—Paclitaxel—ovarian cancer	5.56e-05	0.000354	CcSEcCtD
Diclofenac—Urinary tract disorder—Doxorubicin—ovarian cancer	5.55e-05	0.000354	CcSEcCtD
Diclofenac—Oedema peripheral—Doxorubicin—ovarian cancer	5.53e-05	0.000353	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Docetaxel—ovarian cancer	5.52e-05	0.000352	CcSEcCtD
Diclofenac—Fatigue—Docetaxel—ovarian cancer	5.51e-05	0.000352	CcSEcCtD
Diclofenac—Angiopathy—Epirubicin—ovarian cancer	5.51e-05	0.000351	CcSEcCtD
Diclofenac—Urethral disorder—Doxorubicin—ovarian cancer	5.51e-05	0.000351	CcSEcCtD
Diclofenac—Immune system disorder—Epirubicin—ovarian cancer	5.48e-05	0.00035	CcSEcCtD
Diclofenac—Mediastinal disorder—Epirubicin—ovarian cancer	5.47e-05	0.000349	CcSEcCtD
Diclofenac—Constipation—Docetaxel—ovarian cancer	5.47e-05	0.000349	CcSEcCtD
Diclofenac—Pain—Docetaxel—ovarian cancer	5.47e-05	0.000349	CcSEcCtD
Diclofenac—Chills—Epirubicin—ovarian cancer	5.45e-05	0.000347	CcSEcCtD
Diclofenac—Arrhythmia—Epirubicin—ovarian cancer	5.42e-05	0.000346	CcSEcCtD
Diclofenac—Visual impairment—Doxorubicin—ovarian cancer	5.41e-05	0.000345	CcSEcCtD
Diclofenac—Asthenia—Paclitaxel—ovarian cancer	5.41e-05	0.000345	CcSEcCtD
Diclofenac—Alopecia—Epirubicin—ovarian cancer	5.36e-05	0.000342	CcSEcCtD
Diclofenac—Pruritus—Paclitaxel—ovarian cancer	5.34e-05	0.00034	CcSEcCtD
Diclofenac—Mental disorder—Epirubicin—ovarian cancer	5.32e-05	0.000339	CcSEcCtD
Diclofenac—Erythema multiforme—Doxorubicin—ovarian cancer	5.31e-05	0.000339	CcSEcCtD
Diclofenac—Erythema—Epirubicin—ovarian cancer	5.28e-05	0.000337	CcSEcCtD
Diclofenac—Malnutrition—Epirubicin—ovarian cancer	5.28e-05	0.000337	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—ovarian cancer	5.27e-05	0.000336	CcSEcCtD
Diclofenac—Eye disorder—Doxorubicin—ovarian cancer	5.25e-05	0.000335	CcSEcCtD
Diclofenac—Tinnitus—Doxorubicin—ovarian cancer	5.24e-05	0.000334	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—ovarian cancer	5.23e-05	0.000333	CcSEcCtD
Diclofenac—Flushing—Doxorubicin—ovarian cancer	5.21e-05	0.000332	CcSEcCtD
Diclofenac—Cardiac disorder—Doxorubicin—ovarian cancer	5.21e-05	0.000332	CcSEcCtD
Diclofenac—Flatulence—Epirubicin—ovarian cancer	5.21e-05	0.000332	CcSEcCtD
Diclofenac—Tension—Epirubicin—ovarian cancer	5.18e-05	0.000331	CcSEcCtD
Diclofenac—Dysgeusia—Epirubicin—ovarian cancer	5.17e-05	0.00033	CcSEcCtD
Diclofenac—Diarrhoea—Paclitaxel—ovarian cancer	5.16e-05	0.000329	CcSEcCtD
Diclofenac—Nervousness—Epirubicin—ovarian cancer	5.13e-05	0.000327	CcSEcCtD
Diclofenac—Back pain—Epirubicin—ovarian cancer	5.11e-05	0.000326	CcSEcCtD
Diclofenac—Angiopathy—Doxorubicin—ovarian cancer	5.1e-05	0.000325	CcSEcCtD
Diclofenac—Muscle spasms—Epirubicin—ovarian cancer	5.08e-05	0.000324	CcSEcCtD
Diclofenac—Immune system disorder—Doxorubicin—ovarian cancer	5.07e-05	0.000324	CcSEcCtD
Diclofenac—Mediastinal disorder—Doxorubicin—ovarian cancer	5.06e-05	0.000323	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—ovarian cancer	5.05e-05	0.000322	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—ovarian cancer	5.05e-05	0.000322	CcSEcCtD
Diclofenac—Chills—Doxorubicin—ovarian cancer	5.04e-05	0.000321	CcSEcCtD
Diclofenac—Arrhythmia—Doxorubicin—ovarian cancer	5.02e-05	0.00032	CcSEcCtD
Diclofenac—Dizziness—Paclitaxel—ovarian cancer	4.99e-05	0.000318	CcSEcCtD
Diclofenac—Vision blurred—Epirubicin—ovarian cancer	4.98e-05	0.000318	CcSEcCtD
Diclofenac—Alopecia—Doxorubicin—ovarian cancer	4.96e-05	0.000317	CcSEcCtD
Diclofenac—Mental disorder—Doxorubicin—ovarian cancer	4.92e-05	0.000314	CcSEcCtD
Diclofenac—Ill-defined disorder—Epirubicin—ovarian cancer	4.9e-05	0.000313	CcSEcCtD
Diclofenac—Malnutrition—Doxorubicin—ovarian cancer	4.89e-05	0.000312	CcSEcCtD
Diclofenac—Erythema—Doxorubicin—ovarian cancer	4.89e-05	0.000312	CcSEcCtD
Diclofenac—Anaemia—Epirubicin—ovarian cancer	4.88e-05	0.000311	CcSEcCtD
Diclofenac—Agitation—Epirubicin—ovarian cancer	4.86e-05	0.00031	CcSEcCtD
Diclofenac—Flatulence—Doxorubicin—ovarian cancer	4.82e-05	0.000307	CcSEcCtD
Diclofenac—Tension—Doxorubicin—ovarian cancer	4.8e-05	0.000306	CcSEcCtD
Diclofenac—Vomiting—Paclitaxel—ovarian cancer	4.8e-05	0.000306	CcSEcCtD
Diclofenac—Dysgeusia—Doxorubicin—ovarian cancer	4.79e-05	0.000305	CcSEcCtD
Diclofenac—Malaise—Epirubicin—ovarian cancer	4.76e-05	0.000304	CcSEcCtD
Diclofenac—Rash—Paclitaxel—ovarian cancer	4.76e-05	0.000303	CcSEcCtD
Diclofenac—Dermatitis—Paclitaxel—ovarian cancer	4.75e-05	0.000303	CcSEcCtD
Diclofenac—Nervousness—Doxorubicin—ovarian cancer	4.75e-05	0.000303	CcSEcCtD
Diclofenac—Vertigo—Epirubicin—ovarian cancer	4.75e-05	0.000303	CcSEcCtD
Diclofenac—Syncope—Epirubicin—ovarian cancer	4.74e-05	0.000302	CcSEcCtD
Diclofenac—Leukopenia—Epirubicin—ovarian cancer	4.73e-05	0.000302	CcSEcCtD
Diclofenac—Back pain—Doxorubicin—ovarian cancer	4.73e-05	0.000302	CcSEcCtD
Diclofenac—Headache—Paclitaxel—ovarian cancer	4.73e-05	0.000301	CcSEcCtD
Diclofenac—Hypersensitivity—Docetaxel—ovarian cancer	4.71e-05	0.0003	CcSEcCtD
Diclofenac—Muscle spasms—Doxorubicin—ovarian cancer	4.7e-05	0.0003	CcSEcCtD
Diclofenac—Palpitations—Epirubicin—ovarian cancer	4.67e-05	0.000298	CcSEcCtD
Diclofenac—Loss of consciousness—Epirubicin—ovarian cancer	4.64e-05	0.000296	CcSEcCtD
Diclofenac—Cough—Epirubicin—ovarian cancer	4.61e-05	0.000294	CcSEcCtD
Diclofenac—Vision blurred—Doxorubicin—ovarian cancer	4.61e-05	0.000294	CcSEcCtD
Diclofenac—Asthenia—Docetaxel—ovarian cancer	4.59e-05	0.000293	CcSEcCtD
Diclofenac—Convulsion—Epirubicin—ovarian cancer	4.58e-05	0.000292	CcSEcCtD
Diclofenac—Hypertension—Epirubicin—ovarian cancer	4.56e-05	0.000291	CcSEcCtD
Diclofenac—Ill-defined disorder—Doxorubicin—ovarian cancer	4.54e-05	0.000289	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—ovarian cancer	4.52e-05	0.000289	CcSEcCtD
Diclofenac—Anaemia—Doxorubicin—ovarian cancer	4.52e-05	0.000288	CcSEcCtD
Diclofenac—Myalgia—Epirubicin—ovarian cancer	4.5e-05	0.000287	CcSEcCtD
Diclofenac—Chest pain—Epirubicin—ovarian cancer	4.5e-05	0.000287	CcSEcCtD
Diclofenac—Arthralgia—Epirubicin—ovarian cancer	4.5e-05	0.000287	CcSEcCtD
Diclofenac—Agitation—Doxorubicin—ovarian cancer	4.49e-05	0.000287	CcSEcCtD
Diclofenac—Anxiety—Epirubicin—ovarian cancer	4.48e-05	0.000286	CcSEcCtD
Diclofenac—Nausea—Paclitaxel—ovarian cancer	4.48e-05	0.000286	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	4.47e-05	0.000285	CcSEcCtD
Diclofenac—Discomfort—Epirubicin—ovarian cancer	4.44e-05	0.000283	CcSEcCtD
Diclofenac—Malaise—Doxorubicin—ovarian cancer	4.41e-05	0.000281	CcSEcCtD
Diclofenac—Dry mouth—Epirubicin—ovarian cancer	4.4e-05	0.000281	CcSEcCtD
Diclofenac—Vertigo—Doxorubicin—ovarian cancer	4.39e-05	0.00028	CcSEcCtD
Diclofenac—Syncope—Doxorubicin—ovarian cancer	4.38e-05	0.00028	CcSEcCtD
Diclofenac—Leukopenia—Doxorubicin—ovarian cancer	4.38e-05	0.000279	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—ovarian cancer	4.37e-05	0.000279	CcSEcCtD
Diclofenac—Confusional state—Epirubicin—ovarian cancer	4.35e-05	0.000277	CcSEcCtD
Diclofenac—Palpitations—Doxorubicin—ovarian cancer	4.32e-05	0.000276	CcSEcCtD
Diclofenac—Oedema—Epirubicin—ovarian cancer	4.31e-05	0.000275	CcSEcCtD
Diclofenac—Anaphylactic shock—Epirubicin—ovarian cancer	4.31e-05	0.000275	CcSEcCtD
Diclofenac—Loss of consciousness—Doxorubicin—ovarian cancer	4.3e-05	0.000274	CcSEcCtD
Diclofenac—Infection—Epirubicin—ovarian cancer	4.28e-05	0.000273	CcSEcCtD
Diclofenac—Cough—Doxorubicin—ovarian cancer	4.27e-05	0.000272	CcSEcCtD
Diclofenac—Shock—Epirubicin—ovarian cancer	4.24e-05	0.000271	CcSEcCtD
Diclofenac—Convulsion—Doxorubicin—ovarian cancer	4.24e-05	0.00027	CcSEcCtD
Diclofenac—Nervous system disorder—Epirubicin—ovarian cancer	4.23e-05	0.00027	CcSEcCtD
Diclofenac—Dizziness—Docetaxel—ovarian cancer	4.23e-05	0.00027	CcSEcCtD
Diclofenac—Thrombocytopenia—Epirubicin—ovarian cancer	4.22e-05	0.000269	CcSEcCtD
Diclofenac—Hypertension—Doxorubicin—ovarian cancer	4.22e-05	0.000269	CcSEcCtD
Diclofenac—Tachycardia—Epirubicin—ovarian cancer	4.21e-05	0.000268	CcSEcCtD
Diclofenac—Skin disorder—Epirubicin—ovarian cancer	4.19e-05	0.000267	CcSEcCtD
Diclofenac—Hyperhidrosis—Epirubicin—ovarian cancer	4.17e-05	0.000266	CcSEcCtD
Diclofenac—Arthralgia—Doxorubicin—ovarian cancer	4.16e-05	0.000265	CcSEcCtD
Diclofenac—Myalgia—Doxorubicin—ovarian cancer	4.16e-05	0.000265	CcSEcCtD
Diclofenac—Chest pain—Doxorubicin—ovarian cancer	4.16e-05	0.000265	CcSEcCtD
Diclofenac—Anxiety—Doxorubicin—ovarian cancer	4.15e-05	0.000265	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	4.13e-05	0.000264	CcSEcCtD
Diclofenac—Discomfort—Doxorubicin—ovarian cancer	4.11e-05	0.000262	CcSEcCtD
Diclofenac—Anorexia—Epirubicin—ovarian cancer	4.11e-05	0.000262	CcSEcCtD
Diclofenac—Dry mouth—Doxorubicin—ovarian cancer	4.07e-05	0.00026	CcSEcCtD
Diclofenac—Vomiting—Docetaxel—ovarian cancer	4.06e-05	0.000259	CcSEcCtD
Diclofenac—Rash—Docetaxel—ovarian cancer	4.03e-05	0.000257	CcSEcCtD
Diclofenac—Hypotension—Epirubicin—ovarian cancer	4.03e-05	0.000257	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—ovarian cancer	4.03e-05	0.000257	CcSEcCtD
Diclofenac—Confusional state—Doxorubicin—ovarian cancer	4.02e-05	0.000257	CcSEcCtD
Diclofenac—Headache—Docetaxel—ovarian cancer	4.01e-05	0.000255	CcSEcCtD
Diclofenac—Oedema—Doxorubicin—ovarian cancer	3.99e-05	0.000254	CcSEcCtD
Diclofenac—Anaphylactic shock—Doxorubicin—ovarian cancer	3.99e-05	0.000254	CcSEcCtD
Diclofenac—Infection—Doxorubicin—ovarian cancer	3.96e-05	0.000253	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Epirubicin—ovarian cancer	3.93e-05	0.000251	CcSEcCtD
Diclofenac—Shock—Doxorubicin—ovarian cancer	3.93e-05	0.00025	CcSEcCtD
Diclofenac—Nervous system disorder—Doxorubicin—ovarian cancer	3.91e-05	0.00025	CcSEcCtD
Diclofenac—Thrombocytopenia—Doxorubicin—ovarian cancer	3.91e-05	0.000249	CcSEcCtD
Diclofenac—Insomnia—Epirubicin—ovarian cancer	3.9e-05	0.000249	CcSEcCtD
Diclofenac—Tachycardia—Doxorubicin—ovarian cancer	3.89e-05	0.000248	CcSEcCtD
Diclofenac—Skin disorder—Doxorubicin—ovarian cancer	3.88e-05	0.000247	CcSEcCtD
Diclofenac—Paraesthesia—Epirubicin—ovarian cancer	3.87e-05	0.000247	CcSEcCtD
Diclofenac—Hyperhidrosis—Doxorubicin—ovarian cancer	3.86e-05	0.000246	CcSEcCtD
Diclofenac—Dyspnoea—Epirubicin—ovarian cancer	3.84e-05	0.000245	CcSEcCtD
Diclofenac—Somnolence—Epirubicin—ovarian cancer	3.83e-05	0.000245	CcSEcCtD
Diclofenac—Anorexia—Doxorubicin—ovarian cancer	3.8e-05	0.000243	CcSEcCtD
Diclofenac—Nausea—Docetaxel—ovarian cancer	3.8e-05	0.000242	CcSEcCtD
Diclofenac—Dyspepsia—Epirubicin—ovarian cancer	3.8e-05	0.000242	CcSEcCtD
Diclofenac—Decreased appetite—Epirubicin—ovarian cancer	3.75e-05	0.000239	CcSEcCtD
Diclofenac—Hypotension—Doxorubicin—ovarian cancer	3.73e-05	0.000238	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Epirubicin—ovarian cancer	3.72e-05	0.000237	CcSEcCtD
Diclofenac—Fatigue—Epirubicin—ovarian cancer	3.72e-05	0.000237	CcSEcCtD
Diclofenac—Pain—Epirubicin—ovarian cancer	3.69e-05	0.000235	CcSEcCtD
Diclofenac—Constipation—Epirubicin—ovarian cancer	3.69e-05	0.000235	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.64e-05	0.000232	CcSEcCtD
Diclofenac—Insomnia—Doxorubicin—ovarian cancer	3.61e-05	0.00023	CcSEcCtD
Diclofenac—Paraesthesia—Doxorubicin—ovarian cancer	3.58e-05	0.000229	CcSEcCtD
Diclofenac—Dyspnoea—Doxorubicin—ovarian cancer	3.56e-05	0.000227	CcSEcCtD
Diclofenac—Feeling abnormal—Epirubicin—ovarian cancer	3.55e-05	0.000227	CcSEcCtD
Diclofenac—Somnolence—Doxorubicin—ovarian cancer	3.55e-05	0.000226	CcSEcCtD
Diclofenac—Gastrointestinal pain—Epirubicin—ovarian cancer	3.53e-05	0.000225	CcSEcCtD
Diclofenac—Dyspepsia—Doxorubicin—ovarian cancer	3.51e-05	0.000224	CcSEcCtD
Diclofenac—Decreased appetite—Doxorubicin—ovarian cancer	3.47e-05	0.000221	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.44e-05	0.00022	CcSEcCtD
Diclofenac—Fatigue—Doxorubicin—ovarian cancer	3.44e-05	0.000219	CcSEcCtD
Diclofenac—Urticaria—Epirubicin—ovarian cancer	3.43e-05	0.000219	CcSEcCtD
Diclofenac—Constipation—Doxorubicin—ovarian cancer	3.41e-05	0.000218	CcSEcCtD
Diclofenac—Pain—Doxorubicin—ovarian cancer	3.41e-05	0.000218	CcSEcCtD
Diclofenac—Abdominal pain—Epirubicin—ovarian cancer	3.41e-05	0.000217	CcSEcCtD
Diclofenac—Body temperature increased—Epirubicin—ovarian cancer	3.41e-05	0.000217	CcSEcCtD
Diclofenac—Feeling abnormal—Doxorubicin—ovarian cancer	3.29e-05	0.00021	CcSEcCtD
Diclofenac—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.26e-05	0.000208	CcSEcCtD
Diclofenac—Hypersensitivity—Epirubicin—ovarian cancer	3.18e-05	0.000203	CcSEcCtD
Diclofenac—Urticaria—Doxorubicin—ovarian cancer	3.17e-05	0.000202	CcSEcCtD
Diclofenac—Body temperature increased—Doxorubicin—ovarian cancer	3.15e-05	0.000201	CcSEcCtD
Diclofenac—Abdominal pain—Doxorubicin—ovarian cancer	3.15e-05	0.000201	CcSEcCtD
Diclofenac—Asthenia—Epirubicin—ovarian cancer	3.09e-05	0.000197	CcSEcCtD
Diclofenac—Pruritus—Epirubicin—ovarian cancer	3.05e-05	0.000195	CcSEcCtD
Diclofenac—Diarrhoea—Epirubicin—ovarian cancer	2.95e-05	0.000188	CcSEcCtD
Diclofenac—Hypersensitivity—Doxorubicin—ovarian cancer	2.94e-05	0.000188	CcSEcCtD
Diclofenac—Asthenia—Doxorubicin—ovarian cancer	2.86e-05	0.000183	CcSEcCtD
Diclofenac—Dizziness—Epirubicin—ovarian cancer	2.85e-05	0.000182	CcSEcCtD
Diclofenac—Pruritus—Doxorubicin—ovarian cancer	2.82e-05	0.00018	CcSEcCtD
Diclofenac—Vomiting—Epirubicin—ovarian cancer	2.74e-05	0.000175	CcSEcCtD
Diclofenac—Diarrhoea—Doxorubicin—ovarian cancer	2.73e-05	0.000174	CcSEcCtD
Diclofenac—Rash—Epirubicin—ovarian cancer	2.72e-05	0.000173	CcSEcCtD
Diclofenac—Dermatitis—Epirubicin—ovarian cancer	2.72e-05	0.000173	CcSEcCtD
Diclofenac—Headache—Epirubicin—ovarian cancer	2.7e-05	0.000172	CcSEcCtD
Diclofenac—Dizziness—Doxorubicin—ovarian cancer	2.64e-05	0.000168	CcSEcCtD
Diclofenac—Nausea—Epirubicin—ovarian cancer	2.56e-05	0.000163	CcSEcCtD
Diclofenac—Vomiting—Doxorubicin—ovarian cancer	2.54e-05	0.000162	CcSEcCtD
Diclofenac—Rash—Doxorubicin—ovarian cancer	2.52e-05	0.00016	CcSEcCtD
Diclofenac—Dermatitis—Doxorubicin—ovarian cancer	2.51e-05	0.00016	CcSEcCtD
Diclofenac—Headache—Doxorubicin—ovarian cancer	2.5e-05	0.000159	CcSEcCtD
Diclofenac—Nausea—Doxorubicin—ovarian cancer	2.37e-05	0.000151	CcSEcCtD
Diclofenac—PTGS2—Metabolism—ABCB1—ovarian cancer	5.51e-06	7.31e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CAV1—ovarian cancer	5.49e-06	7.29e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ERBB2—ovarian cancer	5.48e-06	7.28e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN1B—ovarian cancer	5.45e-06	7.24e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP1B1—ovarian cancer	5.44e-06	7.23e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CB—ovarian cancer	5.41e-06	7.19e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MTOR—ovarian cancer	5.41e-06	7.19e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP1B1—ovarian cancer	5.41e-06	7.19e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—TYMS—ovarian cancer	5.41e-06	7.18e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CD—ovarian cancer	5.39e-06	7.16e-05	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AKT1—ovarian cancer	5.39e-06	7.16e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PIK3CA—ovarian cancer	5.39e-06	7.16e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CASP3—ovarian cancer	5.34e-06	7.09e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—FASN—ovarian cancer	5.33e-06	7.08e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL2—ovarian cancer	5.33e-06	7.08e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL6—ovarian cancer	5.3e-06	7.05e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ABCB1—ovarian cancer	5.29e-06	7.03e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PIK3CA—ovarian cancer	5.28e-06	7.01e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	5.26e-06	6.99e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC5A5—ovarian cancer	5.24e-06	6.97e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.24e-06	6.97e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.24e-06	6.96e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—FASN—ovarian cancer	5.2e-06	6.91e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CAV1—ovarian cancer	5.2e-06	6.91e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CD—ovarian cancer	5.2e-06	6.91e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—ovarian cancer	5.2e-06	6.9e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—TYMS—ovarian cancer	5.2e-06	6.9e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.19e-06	6.89e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ABCB1—ovarian cancer	5.18e-06	6.89e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CTNNB1—ovarian cancer	5.15e-06	6.84e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTEN—ovarian cancer	5.14e-06	6.82e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC5A5—ovarian cancer	5.12e-06	6.8e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—ovarian cancer	5.1e-06	6.78e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—YAP1—ovarian cancer	5.1e-06	6.77e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—TYMS—ovarian cancer	5.09e-06	6.76e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1B—ovarian cancer	5.08e-06	6.75e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC2A1—ovarian cancer	5.07e-06	6.73e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—ovarian cancer	5.05e-06	6.7e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.04e-06	6.7e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTEN—ovarian cancer	5.02e-06	6.66e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CG—ovarian cancer	5e-06	6.64e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTEN—ovarian cancer	5e-06	6.64e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.96e-06	6.59e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC2A1—ovarian cancer	4.94e-06	6.57e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6ST—ovarian cancer	4.93e-06	6.55e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—ovarian cancer	4.89e-06	6.5e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ABCB1—ovarian cancer	4.89e-06	6.49e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—ovarian cancer	4.88e-06	6.49e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—FASN—ovarian cancer	4.86e-06	6.46e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.86e-06	6.45e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	4.83e-06	6.41e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.8e-06	6.38e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—TYMS—ovarian cancer	4.8e-06	6.38e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPP2R1A—ovarian cancer	4.8e-06	6.37e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CTNNB1—ovarian cancer	4.8e-06	6.37e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.78e-06	6.35e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.77e-06	6.34e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.74e-06	6.3e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APC—ovarian cancer	4.74e-06	6.3e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—ovarian cancer	4.74e-06	6.29e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CB—ovarian cancer	4.7e-06	6.24e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—ovarian cancer	4.68e-06	6.22e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTEN—ovarian cancer	4.68e-06	6.21e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—ovarian cancer	4.67e-06	6.21e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.62e-06	6.14e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CB—ovarian cancer	4.53e-06	6.02e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—ovarian cancer	4.53e-06	6.02e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.52e-06	6.01e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—ovarian cancer	4.49e-06	5.96e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK3—ovarian cancer	4.48e-06	5.95e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.48e-06	5.95e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—ovarian cancer	4.48e-06	5.95e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ABCB1—ovarian cancer	4.45e-06	5.92e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.43e-06	5.89e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1B1—ovarian cancer	4.43e-06	5.88e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—TYMS—ovarian cancer	4.4e-06	5.85e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—ovarian cancer	4.4e-06	5.85e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CD—ovarian cancer	4.4e-06	5.84e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—TYMS—ovarian cancer	4.38e-06	5.81e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CAV1—ovarian cancer	4.36e-06	5.79e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—ovarian cancer	4.31e-06	5.73e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	4.31e-06	5.72e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK3—ovarian cancer	4.29e-06	5.69e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.29e-06	5.69e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK1—ovarian cancer	4.26e-06	5.66e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPP2R1A—ovarian cancer	4.2e-06	5.58e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CAV1—ovarian cancer	4.19e-06	5.56e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—ovarian cancer	4.18e-06	5.56e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—ovarian cancer	4.17e-06	5.54e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—ovarian cancer	4.17e-06	5.54e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CD—ovarian cancer	4.17e-06	5.53e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.16e-06	5.53e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—FASN—ovarian cancer	4.15e-06	5.52e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CAV1—ovarian cancer	4.1e-06	5.45e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.09e-06	5.43e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK1—ovarian cancer	4.08e-06	5.42e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—ovarian cancer	4.08e-06	5.42e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—ovarian cancer	4.06e-06	5.39e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—ovarian cancer	4.03e-06	5.35e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ABCB1—ovarian cancer	4e-06	5.31e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK3—ovarian cancer	4e-06	5.31e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CG—ovarian cancer	3.97e-06	5.27e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.95e-06	5.24e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—YAP1—ovarian cancer	3.93e-06	5.23e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TYMS—ovarian cancer	3.93e-06	5.22e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.93e-06	5.22e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—ovarian cancer	3.92e-06	5.2e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.91e-06	5.19e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—ovarian cancer	3.89e-06	5.16e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CAV1—ovarian cancer	3.87e-06	5.14e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.86e-06	5.13e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—ovarian cancer	3.85e-06	5.12e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TYMS—ovarian cancer	3.83e-06	5.09e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—ovarian cancer	3.83e-06	5.09e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—ovarian cancer	3.81e-06	5.07e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK1—ovarian cancer	3.8e-06	5.05e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—ovarian cancer	3.8e-06	5.05e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.78e-06	5.03e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.74e-06	4.96e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—ovarian cancer	3.7e-06	4.91e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.69e-06	4.91e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—ovarian cancer	3.68e-06	4.89e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.65e-06	4.84e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MTOR—ovarian cancer	3.63e-06	4.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—ovarian cancer	3.63e-06	4.82e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—ovarian cancer	3.62e-06	4.81e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—ovarian cancer	3.59e-06	4.77e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TYMS—ovarian cancer	3.58e-06	4.76e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—ovarian cancer	3.58e-06	4.75e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CAV1—ovarian cancer	3.55e-06	4.71e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—ovarian cancer	3.54e-06	4.7e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—ovarian cancer	3.53e-06	4.68e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CAV1—ovarian cancer	3.53e-06	4.68e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—ovarian cancer	3.52e-06	4.68e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—ovarian cancer	3.49e-06	4.64e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—ovarian cancer	3.42e-06	4.55e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—ovarian cancer	3.42e-06	4.55e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—ovarian cancer	3.41e-06	4.53e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.39e-06	4.5e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.37e-06	4.47e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.36e-06	4.46e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—ovarian cancer	3.35e-06	4.46e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.34e-06	4.44e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—ovarian cancer	3.31e-06	4.4e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—ovarian cancer	3.3e-06	4.38e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.28e-06	4.36e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—ovarian cancer	3.27e-06	4.35e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.23e-06	4.29e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—ovarian cancer	3.22e-06	4.28e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—ovarian cancer	3.21e-06	4.27e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—FASN—ovarian cancer	3.21e-06	4.26e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CAV1—ovarian cancer	3.16e-06	4.2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.15e-06	4.19e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—ovarian cancer	3.14e-06	4.17e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—ovarian cancer	3.13e-06	4.16e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.12e-06	4.14e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—ovarian cancer	3.1e-06	4.11e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CAV1—ovarian cancer	3.09e-06	4.1e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TYMS—ovarian cancer	3.06e-06	4.07e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—ovarian cancer	3.05e-06	4.05e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.05e-06	4.05e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—ovarian cancer	3.04e-06	4.04e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.02e-06	4.02e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—ovarian cancer	3.02e-06	4.01e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—ovarian cancer	2.96e-06	3.93e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—ovarian cancer	2.92e-06	3.88e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—ovarian cancer	2.92e-06	3.88e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.92e-06	3.88e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—ovarian cancer	2.89e-06	3.84e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CAV1—ovarian cancer	2.89e-06	3.83e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.88e-06	3.83e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—ovarian cancer	2.88e-06	3.83e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—ovarian cancer	2.86e-06	3.81e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.86e-06	3.8e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.84e-06	3.77e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—ovarian cancer	2.82e-06	3.75e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.81e-06	3.74e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—ovarian cancer	2.81e-06	3.73e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—ovarian cancer	2.8e-06	3.72e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—ovarian cancer	2.76e-06	3.67e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.76e-06	3.66e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—ovarian cancer	2.7e-06	3.59e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—ovarian cancer	2.69e-06	3.58e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—ovarian cancer	2.68e-06	3.56e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.63e-06	3.49e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—ovarian cancer	2.63e-06	3.49e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—ovarian cancer	2.61e-06	3.46e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.59e-06	3.44e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK1—ovarian cancer	2.55e-06	3.39e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—ovarian cancer	2.55e-06	3.39e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.53e-06	3.37e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—ovarian cancer	2.53e-06	3.36e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.47e-06	3.29e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—ovarian cancer	2.47e-06	3.29e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.47e-06	3.29e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CAV1—ovarian cancer	2.47e-06	3.28e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—ovarian cancer	2.46e-06	3.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—ovarian cancer	2.41e-06	3.2e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.4e-06	3.19e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMS—ovarian cancer	2.36e-06	3.14e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.36e-06	3.13e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—ovarian cancer	2.34e-06	3.11e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—ovarian cancer	2.34e-06	3.1e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—ovarian cancer	2.33e-06	3.1e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.31e-06	3.07e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—ovarian cancer	2.26e-06	3e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.25e-06	2.98e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—ovarian cancer	2.21e-06	2.94e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—ovarian cancer	2.21e-06	2.93e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.16e-06	2.86e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—ovarian cancer	2.14e-06	2.84e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—ovarian cancer	2.13e-06	2.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—ovarian cancer	2.05e-06	2.72e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.01e-06	2.68e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.97e-06	2.62e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—ovarian cancer	1.96e-06	2.6e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—ovarian cancer	1.91e-06	2.54e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—ovarian cancer	1.91e-06	2.53e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CAV1—ovarian cancer	1.9e-06	2.53e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—ovarian cancer	1.86e-06	2.47e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—ovarian cancer	1.85e-06	2.46e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—ovarian cancer	1.81e-06	2.4e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.78e-06	2.37e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.75e-06	2.32e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—ovarian cancer	1.74e-06	2.31e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.73e-06	2.3e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.72e-06	2.29e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.65e-06	2.19e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.52e-06	2.02e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—ovarian cancer	1.51e-06	2.01e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.51e-06	2e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—ovarian cancer	1.5e-06	1.99e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—ovarian cancer	1.49e-06	1.98e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—ovarian cancer	1.46e-06	1.93e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—ovarian cancer	1.43e-06	1.89e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.35e-06	1.79e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—ovarian cancer	1.34e-06	1.79e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.33e-06	1.76e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.31e-06	1.75e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—ovarian cancer	1.23e-06	1.64e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.23e-06	1.63e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—ovarian cancer	1.23e-06	1.63e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—ovarian cancer	1.15e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—ovarian cancer	1.1e-06	1.46e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—ovarian cancer	1.07e-06	1.43e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.05e-06	1.39e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—ovarian cancer	1e-06	1.33e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—ovarian cancer	8.57e-07	1.14e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.1e-07	1.08e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—ovarian cancer	6.61e-07	8.79e-06	CbGpPWpGaD
